CVRx Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $14.57
- Today's High:
- $15.68
- Open Price:
- $15.51
- 52W Low:
- $5.23
- 52W High:
- $19.94
- Prev. Close:
- $15.65
- Volume:
- 135772
Company Statistics
- Market Cap.:
- $255.37 million
- Book Value:
- 4.812
- Revenue TTM:
- $26.37 million
- Operating Margin TTM:
- -169.8%
- Gross Profit TTM:
- $17.47 million
- Profit Margin:
- -162.34%
- Return on Assets TTM:
- -20.96%
- Return on Equity TTM:
- -36.21%
Company Profile
CVRx Inc had its IPO on 2021-06-30 under the ticker symbol CVRX.
The company operates in the Healthcare sector and Medical Devices industry. CVRx Inc has a staff strength of 160 employees.
Stock update
Shares of CVRx Inc opened at $15.51 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $14.57 - $15.68, and closed at $15.26.
This is a -2.49% slip from the previous day's closing price.
A total volume of 135,772 shares were traded at the close of the day’s session.
In the last one week, shares of CVRx Inc have slipped by -11.79%.
CVRx Inc's Key Ratios
CVRx Inc has a market cap of $255.37 million, indicating a price to book ratio of 2.4006 and a price to sales ratio of 16.2167.
In the last 12-months CVRx Inc’s revenue was $26.37 million with a gross profit of $17.47 million and an EBITDA of $-44302000. The EBITDA ratio measures CVRx Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, CVRx Inc’s operating margin was -169.8% while its return on assets stood at -20.96% with a return of equity of -36.21%.
In Q1, CVRx Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 95.8%.
CVRx Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-2.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CVRx Inc’s profitability.
CVRx Inc stock is trading at a EV to sales ratio of 9.1955 and a EV to EBITDA ratio of -4.2901. Its price to sales ratio in the trailing 12-months stood at 16.2167.
CVRx Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $122.69 million
- Total Liabilities
- $7.96 million
- Operating Cash Flow
- $-240000.00
- Capital Expenditure
- $240000
- Dividend Payout Ratio
- 0%
CVRx Inc ended 2024 with $122.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $122.69 million while shareholder equity stood at $99.64 million.
CVRx Inc ended 2024 with $0 in deferred long-term liabilities, $7.96 million in other current liabilities, 207000.00 in common stock, $-447556000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $103.28 million and cash and short-term investments were $103.28 million. The company’s total short-term debt was $0 while long-term debt stood at $14.22 million.
CVRx Inc’s total current assets stands at $120.58 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $6.43 million compared to accounts payable of $2.00 million and inventory worth $8.24 million.
In 2024, CVRx Inc's operating cash flow was $-240000.00 while its capital expenditure stood at $240000.
Comparatively, CVRx Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $15.26
- 52-Week High
- $19.94
- 52-Week Low
- $5.23
- Analyst Target Price
- $19.75
CVRx Inc stock is currently trading at $15.26 per share. It touched a 52-week high of $19.94 and a 52-week low of $19.94. Analysts tracking the stock have a 12-month average target price of $19.75.
Its 50-day moving average was $16.82 and 200-day moving average was $14 The short ratio stood at 4.11 indicating a short percent outstanding of 0%.
Around 1033.3% of the company’s stock are held by insiders while 7068.2% are held by institutions.
Frequently Asked Questions About CVRx Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.